Clinical trial
Nicotine Pharmacodynamics With a New Oral Nicotine Replacement Product and NiQuitin™ Lozenge: A Study in Healthy Smokers
NCT01075659 is registered in ClinicalTrials.gov with McNeil AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nicotine Pharmacodynamics With a New Oral Nicotine Replacement Product and NiQuitin™ Lozenge: A Study in Healthy Smokers
- Lead sponsor
- McNeil AB
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 2010
- Completion date
- May 31, 2010
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
smoking cessation